InsidersTradesSigma
Track the SinoMab BioScience Ltd. - B stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Market capitalisation: €1.5bn. The latest transaction was filed on 21 August 2026 (Other). Among the most active insiders: LIANG Fang. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
SinoMab BioScience Ltd. is a biopharmaceutical company focused on developing treatments for autoimmune diseases and cancers. It specializes in the research and commercialization of innovative drugs.